• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Theralase Technologies Inc (OP:TLTFF)

0.1430 UNCHANGED
Streaming Delayed Price Updated: 12:04 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,475
Open 0.1403
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1430
Today's Range 0.1403 - 0.1434
52wk Range 0.1157 - 0.2700
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus
September 24, 2025
Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical... 
Via Newsfile
Topics Derivatives
Theralase(R) Extends Warrants
August 29, 2025
Toronto, Ontario--(Newsfile Corp. - August 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage... 
Via Newsfile

Performance

YTD
-25.0%
-25.0%
1 Month
+4.0%
+4.0%
3 Month
-1.4%
-1.4%
6 Month
-3.4%
-3.4%
1 Year
+1.3%
+1.3%

More News

Read More
Theralase(R) Releases 2Q2025 Financial Statements
August 26, 2025
Via Newsfile
CORRECTING AND REPLACING: Theralase(R) Demonstrates Effective Treatment of Herpes
February 13, 2025
Via ACCESS Newswire
Theralase(R) Closes Non-Brokered Private Placement
July 28, 2025
Via Newsfile
Theralase(R) Extends Warrants
June 27, 2025
Via Newsfile
Theralase(R) Closes Non-Brokered Private Placement
June 17, 2025
Via Newsfile
Theralase Completes Annual General and Special Meeting
June 12, 2025
Via Newsfile
Theralase Annual General Meeting
June 05, 2025
Via Newsfile
Theralase(R) 1Q2025 Financial Statements
May 30, 2025
Via Newsfile
CORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025
May 29, 2025
Via Newsfile
Theralase to Present Groundbreaking Research at ASTRO 2025
May 28, 2025
Via Newsfile
Theralase Provides Corporate Update
May 20, 2025
Via Newsfile
Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association
May 05, 2025
Via Newsfile
Theralase Discovers New Mechanism of Action of Lead Drug
April 28, 2025
Via Newsfile
Theralase(R) Closes Non-Brokered Private Placement
April 14, 2025
Via Newsfile
Ruvidar More Effective in the Treatment of Herpes than FDA-Approved Treatments
April 10, 2025
Via Newsfile
Ruvidar Demonstrates 7 Year Complete Response
April 07, 2025
Via Newsfile
Ruvidar Effective in the Treatment of Herpes
March 24, 2025
Via Newsfile
Theralase(R) Releases 2024 Annual Financial Statements
March 12, 2025
Via Newsfile
Theralase(R) Closes Non-Brokered Private Placement
March 11, 2025
Via Newsfile
Theralase(R) Therapy Improves Motor and Non-Motor Function in Parkinson's Patients
March 10, 2025
Via Newsfile
Theralase(R) Demonstrates Efficacy of Rutherrin(R) in Destruction of Non-Hodgkin's Lymphoma
February 25, 2025
Via Newsfile
Topics Death
Theralase(R) Demonstrates Effective Treatment of Herpes
February 12, 2025
Via ACCESS Newswire
Theralase(R) Releases Latest Research on Inactivation of Herpes Simplex Viruses
February 10, 2025
Via ACCESS Newswire

Frequently Asked Questions

Is Theralase Technologies Inc publicly traded?
Yes, Theralase Technologies Inc is publicly traded.
What exchange does Theralase Technologies Inc trade on?
Theralase Technologies Inc trades on the OTC Traded
What is the ticker symbol for Theralase Technologies Inc?
The ticker symbol for Theralase Technologies Inc is TLTFF on the OTC Traded
What is the current price of Theralase Technologies Inc?
The current price of Theralase Technologies Inc is 0.1430
When was Theralase Technologies Inc last traded?
The last trade of Theralase Technologies Inc was at 10/10/25 12:04 PM ET
Recent Quotes
View More
Symbol Price Change (%)
GOOG  237.49
-4.72 (-1.95%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap